Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis

American Journal of Medicine

Volumn 126, Issue 8, 2013, Pages

  Kumbhani, Dharam J ^a   Steg, Ph Gabriel ^b,c,d   Cannon, Christopher P ^e,f   Eagle, Kim A ^g   Smith, Sidney C ^h   Hoffman, Elaine ^d   Goto, Shinya ⁱ   Ohman, E Magnus ^j   Bhatt, Deepak L ^e,f,k  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e HARVARD MEDICAL SCHOOL   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^h UNIVERSITY OF NORTH CAROLINA   (United States)

ⁱ TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k VA BOSTON HEALTHCARE SYSTEM   (United States)

more..

Author keywords

Atherosclerosis; Cardiovascular disease; Compliance adherence; Registry; Secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ADVERSE OUTCOME; AGED; ARTERY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OUTPATIENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; PRIORITY JOURNAL; REGISTER; SECONDARY PREVENTION; SELF CONCEPT; THROMBOSIS; TREATMENT OUTCOME;

EID: 84880643415     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2013.01.033     Document Type: Article

References (34)

1. S.C. Smith Jr., J. Allen, and S.N. Blair AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute Circulation 113 2006 2363 2372
2. S.H. Naderi, J.P. Bestwick, and D.S. Wald Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients Am J Med 125 2012 882 887
3. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones Heart disease and stroke statistics-2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209
4. L.H. Schwamm, G.C. Fonarow, and M.J. Reeves Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack Circulation 119 2009 107 115
5. K.A. Eagle, C.K. Montoye, and A.L. Riba Guideline-based standardized care is associated with substantially lower mortality in Medicare patients with acute myocardial infarction: the American College of Cardiology's Guidelines Applied in Practice (GAP) Projects in Michigan J Am Coll Cardiol 46 2005 1242 1248
6. D.J. Kumbhani, G.C. Fonarow, and C.P. Cannon Predictors of adherence to performance measures in patients with acute myocardial infarction Am J Med 126 2013 74 e1-9
7. P. Vaishnava, and K.A. Eagle Almost getting with the guidelines Am J Med 126 2013 4 5
8. D.L. Bhatt, K.A. Eagle, and E.M. Ohman Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis JAMA 304 2010 1350 1357
9. D.L. Bhatt, P.G. Steg, and E.M. Ohman International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis JAMA 295 2006 180 189
10. P.G. Steg, D.L. Bhatt, and P.W. Wilson One-year cardiovascular event rates in outpatients with atherothrombosis JAMA 297 2007 1197 1206
11. E.M. Ohman, D.L. Bhatt, and P.G. Steg The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design Am Heart J 151 2006 786 e1-10
12. M.J. Alberts, D.L. Bhatt, and J.L. Mas Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry Eur Heart J 30 2009 2318 2326
13. P.M. Ho, D.J. Magid, and S.M. Shetterly Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease Am Heart J 155 2008 772 779
14. P.M. Ho, C.L. Bryson, and J.S. Rumsfeld Medication adherence: its importance in cardiovascular outcomes Circulation 119 2009 3028 3035
15. L. Osterberg, and T. Blaschke Adherence to medication N Engl J Med 353 2005 487 497
16. E.D. Peterson, M.T. Roe, and J. Mulgund Association between hospital process performance and outcomes among patients with acute coronary syndromes JAMA 295 2006 1912 1920
17. L.K. Newby, N.M. LaPointe, and A.Y. Chen Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease Circulation 113 2006 203 212
18. A. Goyal, J.H. Alexander, and G.E. Hafley Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery Ann Thorac Surg 83 2007 993 1001
19. D.J. Kumbhani, C.P. Cannon, and G.C. Fonarow Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes JAMA 302 2009 2207 2213
20. S. Asberg, K.M. Henriksson, and B. Farahmand Ischemic stroke and secondary prevention in clinical practice: a cohort study of 14,529 patients in the Swedish Stroke Register Stroke 41 2010 1338 1342
21. J.N. Rasmussen, A. Chong, and D.A. Alter Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction JAMA 297 2007 177 186
22. P.A. Heidenreich Patient adherence: the next frontier in quality improvement Am J Med 117 2004 130 132
23. E.L. Glader, M. Sjolander, M. Eriksson, and M. Lundberg Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke Stroke 41 2010 397 401
24. J.A. Lardizabal, and P.C. Deedwania Benefits of statin therapy and compliance in high risk cardiovascular patients Vasc Health Risk Manag 6 2010 843 853
25. J. Butler, P.G. Arbogast, and R. BeLue Outpatient adherence to beta-blocker therapy after acute myocardial infarction J Am Coll Cardiol 40 2002 1589 1595
26. C.A. Jackevicius, P. Li, and J.V. Tu Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction Circulation 117 2008 1028 1036
27. K.A. LaBresh, A.G. Ellrodt, R. Gliklich, J. Liljestrand, and R. Peto Get with the guidelines for cardiovascular secondary prevention: pilot results Arch Intern Med 164 2004 203 209
28. K.A. LaBresh, R. Gliklich, J. Liljestrand, R. Peto, and A.G. Ellrodt Using "Get With The Guidelines" to improve cardiovascular secondary prevention Jt Comm J Qual Saf 29 2003 539 550
29. R.H. Mehta, C.K. Montoye, and M. Gallogly Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative JAMA 287 2002 1269 1276
30. T.R. Frieden, and D.M. Berwick The "Million Hearts" initiative-preventing heart attacks and strokes N Engl J Med 365 2011 e27
31. D.L. Bhatt Advancing the care of cardiac patients using registry data: going where randomized clinical trials dare not JAMA 303 2010 2188 2189
32. A.M. Padula, A.R. Pressman, and E. Vittinghoff Placebo adherence and mortality in the Heart and Estrogen/Progestin Replacement Study Am J Med 125 2012 804 810
33. R.I. Horwitz, C.M. Viscoli, and L. Berkman Treatment adherence and risk of death after a myocardial infarction Lancet 336 1990 542 545
34. M.C. Garber, D.P. Nau, S.R. Erickson, J.E. Aikens, and J.B. Lawrence The concordance of self-report with other measures of medication adherence: a summary of the literature Med Care 42 2004 649 652